Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,486 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (402)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05033522	Immunotherapy for Advanced Liver Cancer(ALIVE)	suspended	Phase 2 / Phase 3	150	Mirror Biologics, Inc.INDUSTRY	2	Oct 23, 2025	clinicaltrials
NCT04268888	Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC(TACE-3)	suspended	Phase 2 / Phase 3	522	The Clatterbridge Cancer Centre NHS Foundation TrustOTHER	2	Feb 26, 2025